Presented By: Alisa O’Riley Hannum, PhD

Event Schedule
12:50 - 1:00 pm Check In
1:00 - 2:00 pm Presentation

Program Description

Psychedelic medicines have been used by traditional cultures for thousands of years to support spiritual connection and healing (George, Hanson, Wilkinson, & Garcia-Romeu, 2021). Since the mid-20th century, researchers have explored their potential to enhance psychotherapy, and in the past two decades, clinical studies have demonstrated promising outcomes for conditions such as depression, anxiety, PTSD, end-of-life distress, and substance use disorders (Haikazian et al., 2023; Reiff et al., 2020; Silczuk et al., 2025). Emerging evidence also suggests possible applications in the treatment of chronic pain and other neurological conditions (Czopek et al., 2025).

Despite this growing body of research, the therapeutic use of psychedelics has been constrained by their classification as Schedule I substances in the United States and international bans, which have slowed scientific progress and clinical application (George et al., 2021). In response to the ongoing need for effective treatments, grassroots movements and policy reform efforts have emerged worldwide. In recent years, several countries and U.S. states have taken steps to implement regulated psychedelic programs.

This presentation will examine the potential benefits and challenges of state-regulated psychedelic programs, with a particular focus on programs in the United States. By exploring both the promise and the complexity of regulated psychedelic programs, this session will invite participants to consider the role of psychologists in shaping the future of this emerging field.

Program Level: Introductory

Learning Objectives

1. Identify two potential benefits of psychedelic assisted psychotherapy
2.  Identify two potential benefits of establishing regulated plant medicine programs
3. Identify two potential challenges of establishing regulated plant medicine programs, including challenges related to cultural appropriation, access, equity, training, and safety

1 CE will be available for attendance.